Investors’ data
Latest news
- July 10, 2008
Thallion Announces 2008 Second Quarter Results
- July 7, 2008
Notice of Thallion Pharmaceuticals Fiscal 2008 Second Quarter Conference Call
- June 26, 2008
Thallion receives health canada approval to initiate Phase II study for TLN-232 in metastatic melanoma patients- Company initiates Phase II study with its second oncology product -
Documentation
Webcasts
Webcasts
- July 14, 2008
- 2008 Q2 Earnings AnnouncementThe Webcast will be hosted by Mr. Lloyd M. Segal, Chief Executive Officer and Mr. Michael Singer, Chief Financial Officer of Thallion, and will be followed by a question and answer session.
- April 8, 2008
- 2008 Q1 Earnings AnnouncementThe Webcast will be hosted by Mr. Lloyd M. Segal, Chief Executive Officer and Mr. Michael Singer, Chief Financial Officer of Thallion, and will be followed by a question and answer session.
- March 28, 2008
- Analyst Day Webcast
- February 14, 2008
- 2007 Year End results
The Webcast will be hosted by Mr. Lloyd M. Segal, Chief Executive Officer and Mr. Michael Singer, Chief Financial Officer of Thallion, and will be followed by a question and answer session.
- October 12, 2007
- 2007 third quarter results
The Webcast will be hosted by Mr. Lloyd M. Segal, Chief Executive Officer and Mr. Michael Singer, Chief Financial Officer of Thallion, and will be followed by a question and answer session.Click here to listen to the webcast